CoChat

Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases

Open access
Gámez-Valero, Ana, Lozano-Ramos, Sara Inés, Bancu, Ioana, Lauzurica-Valdemoros, Ricardo, Borràs, Francesc E. · 2015 · Frontiers in Immunology
Cited by 143

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Most cells physiologically release vesicles as way of intercellular communication. The so-called Extracellular Vesicles (EVs) include exosomes, ectosomes, and apoptotic bodies, which basically differ in their composition and subcellular origin. Specifically, EVs found in urine reflect the state of the urinary system, from podocytes to renal-tubular cells, thus making them an excellent source of samples for the study of kidney physiology and pathology. Several groups have focused on defining biomarkers of kidney-related disorders, from graft rejection to metabolic syndromes. So far, the lack of a standard protocol for EVs isolation precludes the possibility of a proper comparison among the different biomarkers proposed in the literature, stressing the need for validation of these biomarkers not only in larger cohorts of patients but also considering the different methods for EVs isolation. In this review, we aim to gather the current knowledge about EVs-related biomarkers in kidney diseases, with a special emphasis in the methods used to date for EVs enrichment, and discussing the need for more specific protocols of EV isolation in clinical practice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2015.00006

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 79

  1. Mittelbrunn, 2011, Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells, Nat Commun, 2, 282, 10.1038/ncomms1285 · DOI · Paper page
  2. Borges, 2013, Extracellular vesicles: structure, function, and potential clinical uses in renal diseases, Braz J Med Biol Res, 46, 824, 10.1590/1414-431X20132964 · DOI · Paper page
  3. Wang, 2014, Urinary extracellular microvesicles: isolation methods and prospects for urinary proteome, Proteomics, 14, 1922, 10.1002/pmic.201300371 · DOI · Paper page
  4. Witwer, 2013, Standardization of sample collection, isolation and analysis methods in extracellular vesicle research, J Extracell Vesicles, 2, 1, 10.3402/jev.v2i0.20360 · DOI · Paper page
  5. Mathivanan, 2010, Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature, Mol Cell Proteomics, 9, 197, 10.1074/mcp.M900152-MCP200 · DOI · Paper page
  6. Ohno, 2013, Roles of exosomes and microvesicles in disease pathogenesis, Adv Drug Deliv Rev, 65, 398, 10.1016/j.addr.2012.07.019 · DOI
  7. Wang, 2012, Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT), Proteomics, 12, 329, 10.1002/pmic.201100477 · DOI · Paper page
  8. Lázaro-Ibáñez, 2014, Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes, Prostate, 74, 1379, 10.1002/pros.22853 · DOI · Paper page
  9. Simpson, 2012, ExoCarta as a resource for exosomal research, J Extracell Vesicles, 1, 10.3402/jev.v1i0.18374 · DOI · Paper page
  10. Mathivanan, 2012, ExoCarta 2012: database of exosomal proteins, RNA and lipids, Nucleic Acids Res, 40, D1241, 10.1093/nar/gkr828 · DOI · Paper page
  11. Kim, 2014, EVpedia: a community web portal for extracellular vesicles research, Bioinformatics, 10.1093/bioinformatics/btu741 · DOI · Paper page
  12. Adachi, 2006, The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins, Genome Biol, 7, R80, 10.1186/gb-2006-7-9-R80 · DOI · Paper page
  13. Pisitkun, 2006, Discovery of urinary biomarkers, Mol Cell Proteomics, 5, 1760, 10.1074/mcp.R600004-MCP200 · DOI · Paper page
  14. Zhou, 2006, Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery, Kidney Int, 69, 1471, 10.1038/sj.ki.5000273 · DOI · Paper page
  15. Jacquillet, 2013, Urinary vesicles: in splendid isolation, Nephrol Dial Transplant, 28, 1332, 10.1093/ndt/gfs599 · DOI
  16. Rood, 2010, Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome, Kidney Int, 78, 810, 10.1038/ki.2010.262 · DOI · Paper page
  17. Musante, 2012, Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment, PLoS One, 7, e37279, 10.1371/journal.pone.0037279 · DOI · Paper page
  18. Salih, 2014, Urinary extracellular vesicles and the kidney: biomarkers and beyond, Am J Physiol Renal Physiol, 306, F1251, 10.1152/ajprenal.00128.2014 · DOI · Paper page
  19. Harding, 1983, Transferrin recycling in reticulocytes: pH and iron are important determinants of ligand binding and processing, Biochem Biophys Res Commun, 113, 650, 10.1016/0006-291X(83)91776-X · DOI · Paper page
  20. Johnstone, 1984, The fate of the transferrin receptor during maturation of sheep reticulocytes in vitro, Biochem Cell Biol, 62, 1246, 10.1139/o84-159 · DOI
  21. Raj, 2012, A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes, Kidney Int, 81, 1263, 10.1038/ki.2012.25 · DOI
  22. Yuana, 2014, Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation, J Extracell Vesicles, 3, 1, 10.3402/jev.v3.23262 · DOI · Paper page
  23. Van Deun, 2014, The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling, J Extracell Vesicles, 3, 24858, 10.3402/jevv3.24858 · doi:10.3402/jevv3.24858
  24. Cvjetkovic, 2014, The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles, J Extracell Vesicles, 3, 10.3402/jev.v3.23111 · DOI · Paper page
  25. Cheruvanky, 2007, Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator, Am J Physiol Renal Physiol, 292, F1657, 10.1152/ajprenal.00434.2006 · DOI · Paper page
  26. Merchant, 2010, Microfiltration isolation of human urinary exosomes for characterization by MS, Proteomics Clin Appl, 4, 84, 10.1002/prca.200800093 · DOI · Paper page
  27. Kalra, 2013, Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma, Proteomics, 13, 3354, 10.1002/pmic.201300282 · DOI · Paper page
  28. Ghosh, 2014, Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins, PLoS One, 9, e110443, 10.1371/journal.pone.0110443 · DOI · Paper page
  29. Schageman, 2013, The complete exosome workflow solution: from isolation to characterization of RNA cargo, Biomed Res Int, 2013, 253957, 10.1155/2013/253957 · DOI · Paper page
  30. Musante, 2014, Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy, Front Endocrinol, 5, 149, 10.3389/fendo.2014.00149 · DOI · Paper page
  31. Alvarez, 2012, Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers, Kidney Int, 82, 1024, 10.1038/ki.2012.256 · DOI · Paper page
  32. Muller, 2014, Isolation of biologically-active exosomes from human plasma, J Immunol Methods, 411, 55, 10.1016/j.jim.2014.06.007 · DOI · Paper page
  33. Böing, 2014, Single-step isolation of extracellular vesicles by size-exclusion chromatography, J Extracell Vesicles, 3, 23430, 10.3402/jev.v3.23430 · DOI · Paper page
  34. Kanwar, 2014, Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes, Lab Chip, 14, 1891, 10.1039/c4lc00136b · DOI · Paper page
  35. Santana, 2014, Microfluidic isolation of cancer-cell-derived microvesicles from hetergeneous extracellular shed vesicle populations, Biomed Microdevices, 16, 869, 10.1007/s10544-014-9891-z · DOI
  36. Channavajjhala, 2014, Optimizing the purification and analysis of miRNAs from urinary exosomes, Clin Chem Lab Med, 52, 345, 10.1515/cclm-2013-0562 · DOI
  37. Wolfe, 1999, Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, N Engl J Med, 341, 1725, 10.1056/NEJM199912023412303 · DOI · Paper page
  38. Miranda, 2010, Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease, Kidney Int, 78, 191, 10.1038/ki.2010.106 · DOI · Paper page
  39. Hoorn, 2005, Prospects for urinary proteomics: exosomes as a source of urinary biomarkers, Nephrology (Carlton), 10, 283, 10.1111/j.1440-1797.2005.00387.x · DOI · Paper page
  40. Dear, 2013, Urinary exosomes: a reservoir for biomarker discovery and potential mediators of intrarenal signalling, Proteomics, 13, 1572, 10.1002/pmic.201200285 · DOI · Paper page
  41. Zhou, 2008, Urinary exosomal transcription factors, a new class of biomarkers for renal disease, Kidney Int, 74, 613, 10.1038/ki.2008.206 · DOI · Paper page
  42. Sonoda, 2009, Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury, Am J Physiol Renal Physiol, 297, F1006, 10.1152/ajprenal.00200.2009 · DOI
  43. Zhou, 2013, Urinary exosomal Wilms’ tumor-1 as a potential biomarker for podocyte injury, Am J Physiol Renal Physiol, 305, F553, 10.1152/ajprenal.00056.2013 · DOI
  44. Gutwein, 2010, ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases, J Biomed Sci, 17, 3, 10.1186/1423-0127-17-3 · doi:10.1186/1423-0127-17-3
  45. Barutta, 2013, Urinary exosomal microRNAs in incipient diabetic nephropathy, PLoS One, 8, e73798, 10.1371/journal.pone.0073798 · DOI · Paper page
  46. Sun, 2012, Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease, Diab Vasc Dis Res, 9, 301, 10.1177/1479164111434318 · DOI
  47. Zubiri, 2014, Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis, J Proteomics, 96, 92, 10.1016/j.jprot.2013.10.037 · DOI · Paper page
  48. Ichii, 2014, Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis, PLoS One, 9, e110383, 10.1371/journal.pone.0110383 · DOI
  49. Moon, 2011, Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy, Proteomics, 11, 2459, 10.1002/pmic.201000443 · DOI · Paper page
  50. Lv, 2013, MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis, Am J Physiol Renal Physiol, 305, F1220, 10.1152/ajprenal.00148.2013 · DOI · Paper page
  51. Lv, 2014, CD2AP mRNA in urinary exosome as biomarker of kidney disease, Clin Chim Acta, 428, 26, 10.1016/j.cca.2013.10.003 · DOI
  52. Peake, 2014, A comparison of the ability of levels of urinary biomarker proteins and exosomal mRNA to predict outcomes after renal transplantation, PLoS One, 9, e98644, 10.1371/journal.pone.0098644 · DOI
  53. Alvarez, 2013, Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation, Transplant Proc, 45, 3719, 10.1016/j.transproceed.2013.08.079 · DOI
  54. Dimuccio, 2014, Urinary CD133+ extracellular vesicles are decreased in kidney transplanted patients with slow graft function and vascular damage, PLoS One, 9, e104490, 10.1371/journal.pone.0104490 · DOI
  55. Hogan, 2009, Characterization of PKD protein-positive exosome-like vesicles, J Am Soc Nephrol, 20, 278, 10.1681/ASN.2008060564 · DOI · Paper page
  56. Bijnsdorp, 2013, Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients, J Extracell Vesicles, 2, 22097, 10.3402/jev.v2i0.22097 · DOI · Paper page
  57. Corcoran, 2014, miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression: extracellular miRNAs as biomarkers for CRPC, Prostate, 74, 1320, 10.1002/pros.22848 · DOI · Paper page
  58. Mitchell, 2009, Can urinary exosomes act as treatment response markers in prostate cancer?, J Transl Med, 7, 4, 10.1186/1479-5876-7-4 · DOI · Paper page
  59. Beckham, 2014, Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression, J Urol, 192, 583, 10.1016/j.juro.2014.02.035 · DOI · Paper page
  60. Perez, 2014, A pilot study on the potential of RNA-associated to urinary vesicles as a suitable non-invasive source for diagnostic purposes in bladder cancer, Cancers, 6, 179, 10.3390/cancers6010179 · DOI
  61. Chen, 2012, Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients, J Proteome Res, 11, 5611, 10.1021/pr3008732 · DOI · Paper page
  62. Raimondo, 2013, Differential protein profiling of renal cell carcinoma urinary exosomes, Mol Biosyst, 9, 1220, 10.1039/c3mb25582d · DOI · Paper page
  63. Lameire, 2005, Acute renal failure, Lancet, 365, 417, 10.1016/S0140-6736(05)17831-3 · doi:10.1016/s0140-6736(05)17831-3 · Paper page
  64. Barrera-Chimal, 2011, Hsp72 is an early and sensitive biomarker to detect acute kidney injury: Hsp72 as a novel biomarker to detect AKI, EMBO Mol Med, 3, 5, 10.1002/emmm.201000105 · DOI
  65. Mishra, 2005, Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery, Lancet, 365, 1231, 10.1016/S0140-6736(05)74811-X · DOI · Paper page
  66. Morales-Buenrostro, 2014, Hsp72 is a novel biomarker to predict acute kidney injury in critically Ill patients, PLoS ONE, 9, e109407, 10.1371/journal.pone.0109407 · DOI
  67. Zhou, 2006, Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury, Kidney Int, 70, 1847, 10.1038/sj.ki.5001874 · DOI · Paper page
  68. Lennon, 2014, The importance of podocyte adhesion for a healthy glomerulus, Front Endocrinol, 5, 160, 10.3389/fendo.2014.00160 · DOI
  69. Suzuki, 2011, The Pathophysiology of IgA Nephropathy, J Am Soc Nephrol, 22, 1795, 10.1681/ASN.2011050464 · DOI · Paper page
  70. Churg, 1995, Renal Disease: Classification and Atlas of Glomerular Disease
  71. Tryggvason, 2006, Thin basement membrane nephropathy, J Am Soc Nephrol, 17, 813, 10.1681/ASN.2005070737 · doi:10.1681/asn.2005070737
  72. Hartung, 2014, Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects, Pediatrics, 134, e833, 10.1542/peds.2013-3646 · DOI · Paper page
  73. Nogueira, 2010, Other biomarkers for detecting prostate cancer, BJU Int, 105, 166, 10.1111/j.1464-410X.2009.09088.x · doi:10.1111/j.1464-410x.2009.09088.x
  74. Hessvik, 2013, Exosomal miRNAs as biomarkers for prostate cancer, Front Genet, 4, 36, 10.3389/fgene.2013.00036 · DOI
  75. Théry, 2009, Membrane vesicles as conveyors of immune responses, Nat Rev Immunol, 9, 581, 10.1038/nri2567 · DOI · Paper page
  76. Cantaluppi, 2012, Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells, Kidney Int, 82, 412, 10.1038/ki.2012.105 · DOI · Paper page
  77. Bitzer, 2012, Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury, Kidney Int, 82, 375, 10.1038/ki.2012.152 · doi:10.1038/ki.2012.152
  78. Chen, 2014, Exosomal ATF3 RNA attenuates pro-inflammatory gene MCP-1 transcription in renal ischemia-reperfusion, J Cell Physiol, 229, 1202, 10.1002/jcp.24554 · DOI
  79. Sanchez, 2014, Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury, Stem Cell Res Ther, 5, 124, 10.1186/scrt514 · DOI

Cited by

See all 143

Metadata

Authors
Gámez-Valero, A., Lozano-Ramos, S. I., Bancu, I., Lauzurica-Valdemoros, R., & Borrà s, F. E.
Venue
Frontiers in Immunology
Published
2015-01-30
Volume
6
Pages
6-6
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2126856293
Cited by
143
References
10
FWCI
7.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases. https://app.cochat.ai/papers/10.3389/fimmu.2015.00006
The paper
Gámez-Valero, A., Lozano-Ramos, S. I., Bancu, I., Lauzurica-Valdemoros, R., & Borrà s, F. E. (2015). Urinary Extracellular Vesicles as Source of Biomarkers in Kidney Diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2015.00006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.